CoChat

3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro

Goulart, Ernesto, de Caires-Junior, Luiz Carlos, Telles-Silva, Kayque Alves, Araujo, Bruno Henrique Silva, Rocco, Silvana Aparecida, Sforca, Mauricio, de Sousa, Irene Layane, Kobayashi, Gerson S, Musso, Camila Manso, Assoni, Amanda Faria, Oliveira, Danyllo, Caldini, Elia, Raia, Silvano, Lelkes, Peter I, Zatz, Mayana · 2020 · Biofabrication
Cited by 129

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The liver is responsible for many metabolic, endocrine and exocrine functions. Approximately 2 million deaths per year are associated with liver failure. Modern 3D bioprinting technologies allied with autologous induced pluripotent stem cells (iPS)-derived grafts could represent a relevant tissue engineering approach to treat end stage liver disease patients. However, protocols that accurately recapitulates liver’s epithelial parenchyma through bioprinting are still underdeveloped. Here we evaluated the impacts of using single cell dispersion (i.e. obtained from conventional bidimensional differentiation) of iPS-derived parenchymal (i.e. hepatocyte-like cells) versus using iPS-derived hepatocyte-like cells spheroids (i.e. three-dimensional cell culture), both in combination with non-parenchymal cells (e.g. mesenchymal and endothelial cells), into final liver tissue functionality. Single cell constructs showed reduced cell survival and hepatic function and unbalanced protein/amino acid metabolism when compared to spheroid printed constructs after 18 days in culture. In addition, single cell printed constructs revealed epithelial-mesenchymal transition, resulting in rapid loss of hepatocyte phenotype. These results indicates the advantage of using spheroid-based bioprinting, contributing to improve current liver bioprinting technology towards future regenerative medicine applications and liver physiology and disease modeling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1088/1758-5090/ab4a30

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 39

  1. Ge, 2016, Treatment of patients with cirrhosis, New Engl. J. Med., 375, 767, 10.1056/NEJMra1504367 · DOI · Paper page
  2. Goldman, 2016, Human pluripotent stem cells: myths and future realities for liver cell therapy, Cell Stem Cell, 18, 703, 10.1016/j.stem.2016.05.019 · DOI
  3. Faulkner-Jones, 2015, Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D, Biofabrication, 7, 10.1088/1758-5090/7/4/044102 · DOI · Paper page
  4. Ma, 2016, Deterministically patterned biomimetic human iPS-derived hepatic model via rapid 3D bioprinting, PNAS, 113, 2206, 10.1073/pnas.1524510113 · DOI · Paper page
  5. Kizawa, 2017, Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery, Biochem. Biophys. Rep., 10, 186, 10.1016/j.bbrep.2017.04.004 · DOI · Paper page
  6. Bishop, 2017, 3D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends, Genes Dis., 4, 185, 10.1016/j.gendis.2017.10.002 · DOI · Paper page
  7. Lee, 2010, Bio-printing of collagen and VEGF-releasing fibrin gel scaffolds for neural stem cell culture, Exp. Neurol., 223, 645, 10.1016/j.expneurol.2010.02.014 · DOI · Paper page
  8. Hsieh, 2015, 3D bioprinting: a new insight into the therapeutic strategy of neural tissue regeneration, Organogenesis, 11, 153, 10.1080/15476278.2015.1123360 · DOI
  9. Ma, 2015, Bioprinting 3D cell-laden hydrogel microarray for screening human periodontal ligament stem cell response to extracellular matrix, Biofabrication, 7, 10.1088/1758-5090/7/4/044105 · DOI · Paper page
  10. Ma, 2017, Bioprinting-based PDLSC-ECM screening for in vivo repair of alveolar bone defect using cell-laden, injectable and photocrosslinkable hydrogels, ACS Biomater. Sci. Eng., 3, 3534, 10.1021/acsbiomaterials.7b00601 · DOI · Paper page
  11. Lee, 2014, Design and fabrication of human skin by three-dimensional bioprinting, Tissue Eng. C, 20, 473, 10.1089/ten.tec.2013.0335 · DOI · Paper page
  12. Ng, 2016, Polyelectrolyte gelatin-chitosan hydrogel optimized for 3D bioprinting in skin tissue engineering, Int. J. Bioprinting, 2, 53, 10.18063/IJB.2016.01.009 · DOI · Paper page
  13. Ma, 2018, 3D spatiotemporal mechanical microenvironment: a hydrogel-based platform for guiding stem cell fate, Adv. Mater., 30, 10.1002/adma.201705911 · DOI · Paper page
  14. Pettinato, 2016, Scalable differentiation of human IPSCs in a multicellular spheroid-based 3D culture into hepatocyte-like cells through direct wnt/β-catenin pathway inhibition, Sci. Rep., 6, 32888, 10.1038/srep32888 · DOI
  15. Meier, 2017, Hepatic differentiation of human IPSCs in different 3D models: a comparative study, Int. J. Mol. Med., 40, 1759, 10.3892/ijmm.2017.3190 · DOI · Paper page
  16. Kamei, 2019, Three-dimensional cultured liver-on-a-chip with mature hepatocyte-like cells derived from human pluripotent stem cells, Biomed. Microdevices, 21, 73, 10.1007/s10544-019-0423-8 · DOI
  17. Goulart, 2019, Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-β, Stem Cell Res. Ther., 10, 258, 10.1186/s13287-019-1367-x · DOI
  18. Rashidi, 2018, 3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo, Arch. Toxicol., 92, 3117, 10.1007/s00204-018-2280-2 · DOI · Paper page
  19. Carnielli, 2018, Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer, Nat. Commun., 9, 359, 10.1038/s41467-018-05696-2 · DOI · Paper page
  20. Fabregat, 2018, The reactome pathway knowledgebase, Nucleic Acids Res., 4, D649, 10.1093/nar/gkx1132 · DOI · Paper page
  21. Mi, 2009, PANTHER pathway: an ontology-based pathway database coupled with data analysis tools, Methods Mol. Biol., 563, 123, 10.1007/978-1-60761-175-2_7 · DOI · Paper page
  22. Chong, 2018, MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis, Nucleic Acids Res., 46, W486, 10.1093/nar/gky310 · DOI · Paper page
  23. Lyu, 2018, Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system, Stem Cell Res. Ther., 9, 92, 10.1186/s13287-018-0839-8 · DOI
  24. Ruiz de Galarreta, 2017, Therapeutic editing of hepatocyte genome in vivo, J. Hepatol., 67, 818, 10.1016/j.jhep.2017.05.012 · DOI
  25. Tang, 2018, The TORC1-regulated CPA complex rewires an RNA processing network to drive autophagy and metabolic reprogramming, Cell Metab., 27, 1040, 10.1016/j.cmet.2018.02.023 · DOI
  26. Cameron, 2015, Recombinant laminins drive the differentiation and self-organization of hESC-derived hepatocytes, Stem Cell Rep., 5, 1250, 10.1016/j.stemcr.2015.10.016 · DOI · Paper page
  27. Wang, 2017, Defined and scalable generation of hepatocyte-like cells from human pluripotent stem cells, J. Vis. Exp., 121, 55355, 10.3791/55355 · DOI
  28. Armstrong, 2016, 3D bioprinting using a templated porous bioink, Adv. Healthcare Mater., 5, 1724, 10.1002/adhm.201600022 · DOI · Paper page
  29. Kim, 2016, Xeno-sensing activity of the aryl hydrocarbon receptor in human pluripotent stem cell-derived hepatocyte-like cells, Sci. Rep., 6, 21684, 10.1038/srep21684 · DOI
  30. Husson, 2003, Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle, Eur. J. Biochem., 270, 1887, 10.1046/j.1432-1033.2003.03559.x · DOI · Paper page
  31. Baiocchini, 2016, Extracellular matrix molecular remodeling in human liver fibrosis evolution, PLoS One, 11, 10.1371/journal.pone.0151736 · DOI · Paper page
  32. Attallah, 2007, Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV, J. Immunoassay Immunochem., 28, 155, 10.1080/15321810701212088 · DOI
  33. Xue, 2013, Hepatic regeneration and the epithelial to mesenchymal transition, World J. Gastroenterol., 19, 1380, 10.3748/wjg.v19.i9.1380 · DOI
  34. Choi, 2009, Epithelial-to-mesenchymal transitions in the liver, Hepatology, 50, 2007, 10.1002/hep.23196 · DOI · Paper page
  35. Zeisberg, 2007, Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition, J. Biol. Chem., 282, 23337, 10.1074/jbc.M700194200 · DOI · Paper page
  36. Zhao, 2016, Epithelial-mesenchymal transition in liver fibrosis, Biomed. Rep., 4, 269, 10.3892/br.2016.578 · DOI · Paper page
  37. Yap, 2013, Enhanced liver progenitor cell survival and differentiation in vivo by spheroid implantation in a vascularized tissue engineering chamber, Biomaterials, 34, 992, 10.1016/j.biomaterials.2013.02.011 · DOI
  38. Cicchini, 2015, Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte, Liver Int., 35, 302, 10.1111/liv.12577 · DOI · Paper page
  39. Li, 2017, A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes, Nat. Commun., 3, 15166, 10.1038/ncomms15166 · DOI

Cited by

See all 129

Metadata

Authors
Goulart, E., de Caires-Junior, L. C., Telles-Silva, K. A., Araujo, B. H. S., Rocco, S. A., Sforca, M., de Sousa, I. L., Kobayashi, G. S., Musso, C. M., Assoni, A. F., Oliveira, D., Caldini, E., Raia, S., Lelkes, P. I., & Zatz, M.
Venue
Biofabrication
Published
2019-11-27
Volume
12
Issue
1
Pages
015010
ISSN
  • 1758-5082 (ISSN-L)
  • 1758-5090
OpenAlex
W2977786572
Cited by
129
References
9
FWCI
6.30
Type
journal article
Language
en
Open access
closed
Licence
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08028-1)
  • INCT Envelhecimento e Doenças Genéticas: Genômica e Metagenômica (2014/50931-3)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro. https://app.cochat.ai/papers/10.1088/1758-5090/ab4a30
The paper
Goulart, E., de Caires-Junior, L. C., Telles-Silva, K. A., Araujo, B. H. S., Rocco, S. A., Sforca, M., de Sousa, I. L., Kobayashi, G. S., Musso, C. M., Assoni, A. F., Oliveira, D., Caldini, E., Raia, S., Lelkes, P. I., & Zatz, M. (2020). 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro. Biofabrication. https://doi.org/10.1088/1758-5090/ab4a30

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.